Link to this page
National Cancer Institute Thesaurus
Last uploaded:
February 23, 2024
Jump to:
| Preferred Name | Canagliflozin Anhydrous | |
| Synonyms |
Canagliflozin Anhydrous CANAGLIFLOZIN ANHYDROUS |
|
| Definitions |
The anhydrous form of canagliflozin, a C-glucoside with a thiophene ring that is an orally available inhibitor of sodium-glucose transporter 2 (SGLT2) with antihyperglycemic activity. Canagliflozin is also able to reduce body weight and has a low risk for hypoglycemia. |
|
| ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C91019 |
|
| CAS_Registry |
842133-18-0
|
|
| Chemical_Formula |
C24H25FO5S
|
|
| code |
C91019
|
|
| Concept_In_Subset | ||
| Contributing_Source |
FDA
|
|
| DEFINITION |
The anhydrous form of canagliflozin, a C-glucoside with a thiophene ring that is an orally available inhibitor of sodium-glucose transporter 2 (SGLT2) with antihyperglycemic activity. Canagliflozin is also able to reduce body weight and has a low risk for hypoglycemia.
|
|
| FDA_UNII_Code |
6S49DGR869
|
|
| FULL_SYN |
Canagliflozin Anhydrous CANAGLIFLOZIN ANHYDROUS
|
|
| label |
Canagliflozin Anhydrous
|
|
| Preferred_Name |
Canagliflozin Anhydrous
|
|
| prefixIRI |
Thesaurus:C91019
|
|
| Semantic_Type |
Organic Chemical Pharmacologic Substance
|
|
| UMLS_CUI |
C2983989
|
|
| subClassOf |
Add comment
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |